# Glycobiosciences, Inc.

- Location (FDA's records): Mississauga, Ontario, CA
- FDA decisions: 4 (2012–2015): 4 510(k) clearances
- Product codes: FRO (4)
- Predicates its devices cite: 11 (3 its own); citations of its devices by later devices: 3 (3 its own)
- Recalls linked to its devices: 1 (1 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- L.A.M. Pharmaceutical, Corp.: 3 (https://510kreport.com/company/lam-pharmaceutical)
- Fidia Pharmaceutical Corp.: 2 (https://510kreport.com/company/fidia-pharmaceutical)
- Carrington Laboratories, Inc.: 1 (https://510kreport.com/company/carrington-laboratories)
- Oculus Innovative Sciences: 1 (https://510kreport.com/company/oculus-innovative-sciences)
- Stiefel Laboratories, Inc.: 1 (https://510kreport.com/company/stiefel-laboratories)

## Its most-cited devices
- K130781: L.a.M. Ipm Wound Gel, Ipm Derm Gel (2014), cited by 1
- K123113: L.a.M. Imp Wound Gel (2012), cited by 1
- K123193: Ipm Wound Gel Bio (2014), cited by 1

## Recent decisions
- K143527: IPM Wound Gel Bio, IPM Derm Gel Bio (Apr 20, 2015)
- K123193: Ipm Wound Gel Bio (Mar 3, 2014)
- K130781: L.a.M. Ipm Wound Gel, Ipm Derm Gel (Feb 14, 2014)
- K123113: L.a.M. Imp Wound Gel (Dec 11, 2012)

Source page: https://510kreport.com/company/glycobiosciences